A5084099096- Neurological Disorders and Treatments
- Machine Learning in Bioinformatics
- Diabetes and associated disorders
- Pharmacology and Obesity Treatment
- Ferroptosis and cancer prognosis
- Mitochondrial Function and Pathology
- Advanced Proteomics Techniques and Applications
- Lipoproteins and Cardiovascular Health
- Thyroid Disorders and Treatments
- Adrenal Hormones and Disorders
- GDF15 and Related Biomarkers
- Alzheimer's disease research and treatments
- Diabetes Treatment and Management
Kunming Medical University
2021-2024
The incidence of diabetes-associated cognitive dysfunction (DACD) is increasing; however, few clinical intervention measures are available for the prevention and treatment this disease. Research has shown that proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, particularly SBC-115076, have a protective effect against various neurodegenerative diseases. However, their role in DACD remains unknown. In study, we aimed to explore impact PCSK9 inhibitors on DACD.
Background Diabetes-associated cognitive dysfunction (DACD) is a chronic ailment that exerts substantial influence on the overall well-being of individuals. The hippocampus assumes pivotal role in progression and sustenance impairment. identification differentially expressed proteins (DEPs) crucial for understanding mechanisms DACD.
The present work selected 120 patients, affected by diabetes, as control subjects in the Affiliated Hospital of Kunming Medical University. According to principle random distribution, two groups were established, miglitol study group (65 cases) and metformin (55 cases). Ag + disinfectant sampling needle is a rapid detection tool evaluate efficacy diabetes both groups. related biochemical indexes patients measured before after treatment at 3rd, 6th, 12th weeks. test results showed that there...
Purpose: To study the clinical effect of combining insulin aspart with different drugs in treatment oftype 2 diabetes mellitus (T2DM).Methods: Two hundred and thirty-seven T2DM patients admitted to Endocrinology Department Second Affiliated Hospital Kunming Medical University from March September 2018 were selected as subjects this study. Miglitol metformin used combination T2DM. In addition, data on effectiveness safety options,such patient’s weight, waist circumference, blood glucose...